{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:12:12Z","timestamp":1794467532504,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH324"],"award-info":[{"award-number":["ZR2021MH324"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Development Project of Shandong Province","award":["2018GSF118072"],"award-info":[{"award-number":["2018GSF118072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A nomogram for assessing the risk of IgA vasculitis nephritis (originally termed Henoch\u2013Sch\u00f6nlein purpura nephritis, HSPN) in IgA vasculitis (originally termed Henoch\u2013Sch\u00f6nlein purpura, HSP) pediatric patients can effectively improve early diagnosis and prognosis of IgA vasculitis nephritis. However, currently, no nomogram is available. 246 IgA vasculitis and 142 IgA vasculitis nephritis Asian pediatric patients confirmed by renal biopsy were enrolled. Univariate and multivariate logistic regressions were performed to identify the independent risk factors and construct a series of predictive models. The receiver operating characteristic curve, calibration plot, decision curve analysis, net reclassification index and integrated discrimination index were used to screen the best model. Stratification analysis was applied to optimize model\u2019s clinical utility. An external validation set was introduced to verify the predictive efficiency. The final predictive model was converted to nomogram for visual use. We identified age, duration of rash (Dor), D-dimer and IgG as independent risk factors and constructed four models as follows: AIDD (Age\u2009+\u2009IgG\u2009+\u2009Dor\u2009+\u2009D-dimer), AIDi (Age\u2009+\u2009IgG\u2009+\u2009D-dimer), AIDo (Age\u2009+\u2009IgG\u2009+\u2009Dor) and ADD (Age\u2009+\u2009Dor\u2009+\u2009D-dimer), which achieved the receiver operator characteristic curve (AUROC) of 0.931, 0.920, 0.856 and 0.907, respectively. Finally, AIDi model with an AUROC of 0.956 and 0.897 in internal and external validating sets was proposed as a novel predictive model. In stratification analysis by gender and histological grade, the AUROC of AIDi was 0.949 in female, 0.926 in male, 0.933 in mild histological grades and 0.939 in severe histological grades, respectively. AIDi nomogram is an effective and visual tool for assessing the risk of nephritis in IgA vasculitis Asian pediatric patients, regardless of IgA vasculitis nephritis histological grades and gender.<\/jats:p>","DOI":"10.1038\/s41598-022-20369-3","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T10:06:50Z","timestamp":1665137210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A simple nomogram for assessing the risk of IgA vasculitis nephritis in IgA vasculitis Asian pediatric patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuna","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"20369_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00467-014-2815-6","volume":"30","author":"M Pohl","year":"2015","unstructured":"Pohl, M. Henoch\u2013Schonlein purpura nephritis. Pediatr. Nephrol. 30, 245\u2013252. https:\/\/doi.org\/10.1007\/s00467-014-2815-6 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"20369_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2014.126","volume":"10","author":"J Davin","year":"2014","unstructured":"Davin, J. & Coppo, R. Henoch\u2013Sch\u00f6nlein purpura nephritis in children. Nat. Rev. Nephrol. 10, 563\u2013573. https:\/\/doi.org\/10.1038\/nrneph.2014.126 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"20369_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00467-012-2106-z","volume":"27","author":"O Jauhola","year":"2012","unstructured":"Jauhola, O. et al. Outcome of Henoch\u2013Schonlein purpura 8\u00a0years after treatment with a placebo or prednisone at disease onset. Pediatr. Nephrol. 27, 933\u2013939. https:\/\/doi.org\/10.1007\/s00467-012-2106-z (2012).","journal-title":"Pediatr. Nephrol."},{"key":"20369_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1177\/0300060514530879","volume":"42","author":"Y Mao","year":"2014","unstructured":"Mao, Y. et al. Henoch\u2013Schonlein purpura in 535 Chinese children: Clinical features and risk factors for renal involvement. J. Int. Med. Res. 42, 1043\u20131049. https:\/\/doi.org\/10.1177\/0300060514530879 (2014).","journal-title":"J. Int. Med. Res."},{"key":"20369_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s10067-017-3972-3","volume":"37","author":"IM Buscatti","year":"2018","unstructured":"Buscatti, I. M. et al. Henoch\u2013Schonlein purpura nephritis: Initial risk factors and outcomes in a Latin American tertiary center. Clin. Rheumatol. 37, 1319\u20131324. https:\/\/doi.org\/10.1007\/s10067-017-3972-3 (2018).","journal-title":"Clin. Rheumatol."},{"key":"20369_CR6","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/j.1651-2227.2009.01445.x","volume":"98","author":"R Bogdanovic","year":"2009","unstructured":"Bogdanovic, R. Henoch\u2013Schonlein purpura nephritis in children: Risk factors, prevention and treatment. Acta Paediatr. 98, 1882\u20131889. https:\/\/doi.org\/10.1111\/j.1651-2227.2009.01445.x (2009).","journal-title":"Acta Paediatr."},{"key":"20369_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/03009740510026841","volume":"35","author":"JI Shin","year":"2006","unstructured":"Shin, J. I. et al. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch\u2013Schonlein purpura. Scand J. Rheumatol. 35, 56\u201360. https:\/\/doi.org\/10.1080\/03009740510026841 (2006).","journal-title":"Scand J. Rheumatol."},{"key":"20369_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.17219\/acem\/112566","volume":"29","author":"K Dyga","year":"2020","unstructured":"Dyga, K. & Szczepanska, M. IgA vasculitis with nephritis in children. Adv. Clin. Exp. Med. 29, 513\u2013519. https:\/\/doi.org\/10.17219\/acem\/112566 (2020).","journal-title":"Adv. Clin. Exp. Med."},{"key":"20369_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.22034\/iji.2021.89742.1964","volume":"18","author":"Q Su","year":"2021","unstructured":"Su, Q. et al. Changes of peripheral blood lymphocyte subsets and immune function in children with Henoch\u2013Schonlein purpura nephritis. Iran. J. Immunol. 18, 259\u2013267. https:\/\/doi.org\/10.22034\/iji.2021.89742.1964 (2021).","journal-title":"Iran. J. Immunol."},{"key":"20369_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13052-018-0538-1","volume":"44","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Significance of glomerular fibrinogen deposition in children with Henoch\u2013Schonlein purpura nephritis. Ital. J. Pediatr. 44, 97. https:\/\/doi.org\/10.1186\/s13052-018-0538-1 (2018).","journal-title":"Ital. J. Pediatr."},{"key":"20369_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3109\/0886022X.2015.1061668","volume":"37","author":"M Tian","year":"2015","unstructured":"Tian, M. & Liu, C. Heparin calcium treated Henoch\u2013Schonlein purpura nephritis in children through inhibiting hyperfibrinolysis. Ren. Fail. 37, 1100\u20131104. https:\/\/doi.org\/10.3109\/0886022X.2015.1061668 (2015).","journal-title":"Ren. Fail."},{"key":"20369_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007091","volume":"96","author":"H Xu","year":"2017","unstructured":"Xu, H., Li, W., Mao, J. H. & Pan, Y. X. Association between red blood cell distribution width and Henoch\u2013Schonlein purpura nephritis. Medicine (Baltimore) 96, e7091. https:\/\/doi.org\/10.1097\/MD.0000000000007091 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"20369_CR13","first-page":"1710","volume":"13","author":"G Zou","year":"2021","unstructured":"Zou, G. & Gao, H. The relationship between neutrophil\u2013lymphocyte ratio and early renal fibrosis and renal prognosis in patients with lupus nephritis. Am. J. Transl. Res. 13, 1710\u20131716 (2021).","journal-title":"Am. J. Transl. Res."},{"key":"20369_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/0961203320929753","volume":"29","author":"P Liu","year":"2020","unstructured":"Liu, P. et al. Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis. Lupus 29, 1031\u20131039. https:\/\/doi.org\/10.1177\/0961203320929753 (2020).","journal-title":"Lupus"},{"key":"20369_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00045391-200101000-00004","volume":"8","author":"J Prandota","year":"2001","unstructured":"Prandota, J., Pankow-Prandota, L. & Kotecki, L. Impaired activation of the fibrinolytic system in children with Henoch\u2013Schonlein purpura: Beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am. J. Ther. 8, 11\u201319. https:\/\/doi.org\/10.1097\/00045391-200101000-00004 (2001).","journal-title":"Am. J. Ther."},{"key":"20369_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s004670100033","volume":"16","author":"K Brendel-Muller","year":"2001","unstructured":"Brendel-Muller, K., Hahn, A., Schneppenheim, R. & Santer, R. Laboratory signs of activated coagulation are common in Henoch\u2013Schonlein purpura. Pediatr. Nephrol. 16, 1084\u20131088. https:\/\/doi.org\/10.1007\/s004670100033 (2001).","journal-title":"Pediatr. Nephrol."},{"key":"20369_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/08880010590896251","volume":"22","author":"D Yilmaz","year":"2005","unstructured":"Yilmaz, D., Kavakli, K. & Ozkayin, N. The elevated markers of hypercoagulability in children with Henoch\u2013Schonlein purpura. Pediatr. Hematol. Oncol. 22, 41\u201348. https:\/\/doi.org\/10.1080\/08880010590896251 (2005).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"20369_CR18","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s00467-020-04818-7","volume":"36","author":"L Peruzzi","year":"2021","unstructured":"Peruzzi, L. & Coppo, R. IgA vasculitis nephritis in children and adults: One or different entities?. Pediatr. Nephrol. 36, 2615\u20132625. https:\/\/doi.org\/10.1007\/s00467-020-04818-7 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"20369_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1053\/j.ajkd.2004.10.020","volume":"45","author":"S Hisano","year":"2005","unstructured":"Hisano, S., Matsushita, M., Fujita, T. & Iwasaki, H. Activation of the lectin complement pathway in Henoch\u2013Schonlein purpura nephritis. Am. J. Kidney Dis. 45, 295\u2013302. https:\/\/doi.org\/10.1053\/j.ajkd.2004.10.020 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"20369_CR20","first-page":"601","volume":"61","author":"H Yokoyama","year":"1985","unstructured":"Yokoyama, H. et al. Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum immunoglobulin levels. Clin. Exp. Immunol. 61, 601\u2013607 (1985).","journal-title":"Clin. Exp. Immunol."},{"key":"20369_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/ard.2009.116624","volume":"69","author":"N Ruperto","year":"2010","unstructured":"Ruperto, N. et al. EULAR\/PRINTO\/PRES criteria for Henoch\u2013Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann. Rheum. Dis. 69, 790\u2013797. https:\/\/doi.org\/10.1136\/ard.2009.116624 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"20369_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bmj.2.6078.11","volume":"2","author":"R Counahan","year":"1977","unstructured":"Counahan, R. et al. Prognosis of Henoch\u2013Schonlein nephritis in children. Br. Med. J. 2, 11\u201314. https:\/\/doi.org\/10.1136\/bmj.2.6078.11 (1977).","journal-title":"Br. Med. J."},{"key":"20369_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00467-010-1741-5","volume":"26","author":"T Ninchoji","year":"2011","unstructured":"Ninchoji, T. et al. Treatment strategies for Henoch\u2013Schonlein purpura nephritis by histological and clinical severity. Pediatr. Nephrol. 26, 563\u2013569. https:\/\/doi.org\/10.1007\/s00467-010-1741-5 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"20369_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12519-014-0534-5","volume":"11","author":"J Chen","year":"2015","unstructured":"Chen, J. & Mao, J. Henoch\u2013Sch\u00f6nlein purpura nephritis in children: Incidence, pathogenesis and management. World J. Pediatr. 11, 29\u201334. https:\/\/doi.org\/10.1007\/s12519-014-0534-5 (2015).","journal-title":"World J. Pediatr."},{"key":"20369_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.7326\/M13-1522","volume":"160","author":"MJ Leening","year":"2014","unstructured":"Leening, M. J. et al. Net reclassification improvement: Computation, interpretation, and controversies: A literature review and clinician\u2019s guide. Ann. Intern. Med. 160, 122\u2013131. https:\/\/doi.org\/10.7326\/M13-1522 (2014).","journal-title":"Ann. Intern. Med."},{"key":"20369_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/atm.2017.04.01","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. & Kattan, M. W. Drawing Nomograms with R: Applications to categorical outcome and survival data. Ann. Transl. Med. 5, 211. https:\/\/doi.org\/10.21037\/atm.2017.04.01 (2017).","journal-title":"Ann. Transl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20369-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20369-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20369-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T10:14:40Z","timestamp":1665137680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20369-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20369-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16809"}}